Your browser doesn't support javascript.
loading
Incidence of severe uterine bleeding outcomes among oral anticoagulant users and nonusers.
Huang, Ting-Ying; Hou, Laura; Anderson, Abby; Gassman, Audrey; Moeny, David; Eworuke, Efe.
Afiliação
  • Huang TY; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215. Electronic address: jane_huang@harvardpilgrim.org.
  • Hou L; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215.
  • Anderson A; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Gassman A; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Moeny D; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Eworuke E; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Am J Obstet Gynecol ; 226(1): 140-143, 2022 01.
Article em En | MEDLINE | ID: mdl-34481779
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemorragia Uterina / Anticoagulantes Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemorragia Uterina / Anticoagulantes Idioma: En Ano de publicação: 2022 Tipo de documento: Article